Related Experiment Videos
Cancer cachexia: the molecular mechanisms
Josep M Argilés1, Rodrigo Moore-Carrasco, Gemma Fuster
1Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Diagonal 645, 08071, Barcelona, Spain. argiles@porthos.bio.ub.es
The International Journal of Biochemistry & Cell Biology
|February 5, 2003
Summary
Cancer cachexia, a syndrome of weight loss and malnutrition in advanced cancer patients, involves complex tumor-host interactions. This review evaluates catabolic mediators that drive this condition, offering potential therapeutic targets.
Area of Science:
- Oncology
- Metabolic Medicine
- Molecular Biology
Background:
- Cancer cachexia is a complex syndrome characterized by significant weight loss, anorexia, asthenia, and anemia in advanced cancer patients.
- This condition is closely linked to tumor presence and growth, leading to malnutrition through reduced food intake and accelerated starvation.
- Metabolic disturbances, including hypermetabolism and energetic inefficiency, are hallmarks of cancer cachexia.
Purpose of the Study:
- To review and evaluate the various catabolic mediators involved in cancer cachexia.
- To identify potential targets for future clinical investigations and therapeutic strategies.
Main Methods:
- This is a review article, synthesizing existing scientific literature.
- Evaluation of humoral and tumoral factors implicated in cancer cachexia.
Main Results:
- The exact cachectic factors remain largely unknown despite extensive research efforts.
- Numerous humoral and tumoral mediators contribute to the catabolic state in cancer cachexia.
Conclusions:
- Understanding the diverse catabolic mediators is crucial for developing effective treatments for cancer cachexia.
- These mediators represent promising targets for future clinical interventions to combat cancer-induced malnutrition and metabolic dysfunction.